14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of OCUP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Ocuphire Pharma, Inc. stock price after Tuesday trading.
(Updated on Apr 23, 2024)

Sell candidate since Apr 02, 2024 Loss -29.36% PDF

The Ocuphire Pharma, Inc. stock price gained 1.99% on the last trading day (Tuesday, 23rd Apr 2024), rising from $1.51 to $1.54. During the last trading day the stock fluctuated 4.64% from a day low at $1.51 to a day high of $1.58. The price has fallen in 6 of the last 10 days and is down by -17.2% for this period. Volume fell on the last day by -238 thousand shares and in total, 140 thousand shares were bought and sold for approximately $216.25 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.49 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -37.79% during the next 3 months and, with a 90% probability hold a price between $0.93 and $1.20 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OCUP Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 22, 2024, and so far it has risen 1.99%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ocuphire Pharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.66 and $1.95. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Ocuphire Pharma, Inc. stock

Ocuphire Pharma, Inc. finds support from accumulated volume at $1.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0700 between high and low, or 4.64%. For the last week the stock has had daily average volatility of 5.78%.

Ocuphire Pharma, Inc. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OCUP) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Ocuphire Pharma, Inc. to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.42 and $1.66, which gives a possible trading interval of +/-$0.119 (+/-7.73%) up or down from last closing price. If Ocuphire Pharma, Inc. takes out the full calculated possible swing range there will be an estimated 15.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.51 (1.95%) than the resistance at $1.84 (19.48%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ocuphire Pharma, Inc. stock A Buy?

Ocuphire Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.865 Sell Candidate Upgraded

Predicted Opening Price for Ocuphire Pharma, Inc. of Wednesday, April 24, 2024

Fair opening price April 24, 2024 Current price
$1.54 ( 0.216%) $1.54

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OCUP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.61 4.76 %
R2 1.59 3.03 %
R1 1.57 1.95 %
Current price: 1.54
Support S1 1.52 -1.52 %
S2 1.50 -2.59 %
S3 1.47 -4.33 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.91 24.03 %
R2 1.89 22.73 %
R1 1.84 19.48 %
Current price 1.54
Support S1 1.51 -1.95%
S2 0 .
S3 0 .

FAQ

What is the symbol for Ocuphire Pharma, Inc. Stock and on which exchange is it traded?
The symbol for Ocuphire Pharma, Inc. is OCUP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocuphire Pharma, Inc. Stock?
Ocuphire Pharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Ocuphire Pharma, Inc. Stock?
Ocuphire Pharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocuphire Pharma, Inc. Stock.

What's the current price of Ocuphire Pharma, Inc. Stock?
As of the end of day on the Apr 23, 2024, the price of an Ocuphire Pharma, Inc. (OCUP) share was $1.54.

What is the 52-week high and low for Ocuphire Pharma, Inc. Stock?
The 52-week high for Ocuphire Pharma, Inc. Stock is $6.60 and the 52-week low is $1.50.

What is the market capitalization of Ocuphire Pharma, Inc. Stock?
As of the Apr 23, 2024, the market capitalization of Ocuphire Pharma, Inc. is 38.213M.

When is the next earnings date for Ocuphire Pharma, Inc.?
The upcoming earnings date for Ocuphire Pharma, Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Ocuphire Pharma, Inc.

Ocuphire Pharma. Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical trial for dim light or night vision disturbances; and Phase 2b clinical trial for pharmacologically induc... OCUP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT